Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oscar Health A | OSCR | Jan 14, 2025 | 14.93 | +5.36 |
Oshkosh | OSK | Jan 14, 2025 | 93.02 | +1.34 |
OSI Systems | OSIS | Jan 14, 2025 | 158.19 | +2.35 |
Osisko Development | ODV | Jan 14, 2025 | 1.58 | +0.64 |
Osisko Gold Royalties | OR | Jan 14, 2025 | 18.73 | +2.52 |
Ostin Technology Group | OST | Jan 14, 2025 | 2.44 | +11.42 |
Otis Worldwide | OTIS | Jan 14, 2025 | 91.78 | +0.68 |
Otter Tail | OTTR | Jan 14, 2025 | 77.37 | +1.95 |
Ouster | OUST | Jan 14, 2025 | 10.73 | -1.11 |
Outbrain | OB | Jan 14, 2025 | 6.28 | +2.45 |
Outfront Media | OUT | Jan 14, 2025 | 17.20 | +1.42 |
Outlook Therapeutics | OTLK | Jan 14, 2025 | 2.16 | -5.68 |
Outset Medical | OM | Jan 14, 2025 | 0.81 | +0.53 |
Ovid Therapeutics | OVID | Jan 14, 2025 | 0.76 | -5.86 |
Ovintiv | OVV | Jan 14, 2025 | 44.98 | +0.85 |
Owens & Minor | OMI | Jan 14, 2025 | 14.74 | +1.17 |
Owens Corning | OC | Jan 14, 2025 | 174.60 | +3.01 |
Owlet A | OWLT | Jan 14, 2025 | 4.50 | 0.00 |
Oxbridge Re | OXBR | Jan 14, 2025 | 3.78 | -4.06 |
Oxford Industries | OXM | Jan 14, 2025 | 86.12 | -0.86 |
Oxford Lane Capital | OXLC | Jan 14, 2025 | 5.11 | +0.59 |
Oxford Lane Capital 2027 Pref | OXLCP | Jan 14, 2025 | 24.11 | +0.16 |
Oxford Square Capital | OXSQ | Jan 14, 2025 | 2.61 | +1.95 |
P10 | PX | Jan 14, 2025 | 12.99 | +1.72 |
P3 Health Partners A | PIII | Jan 14, 2025 | 0.23 | +5.63 |
PACCAR | PCAR | Jan 14, 2025 | 110.20 | +1.89 |
Pacific Biosciences of California | PACB | Jan 14, 2025 | 1.85 | -7.96 |
Pacific ETF FTSE Vanguard | VPL | Jan 14, 2025 | 70.24 | +0.13 |
Pacific Ex-Japan MSCI Ishares | EPP | Jan 14, 2025 | 43.52 | +0.39 |
Pacific Gas & Electric | PCG | Jan 14, 2025 | 16.22 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.